Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.
Personalized Alzheimer’s Progression Predicted by Model
A model to predict individual cognitive decline in Alzheimer’s disease was developed. The predictions can give patients a general indication of their Alzheimer’s course. The